See the DrugPatentWatch profile for lipitor

Based on the information available, there is no definitive evidence or studies indicating long-term risks of Lipitor (atorvastatin) for bovines. Lipitor is a medication primarily used in humans to lower cholesterol levels and reduce the risk of heart disease [1].

It is important to note that Lipitor is not approved for use in animals, including bovines, by the Food and Drug Administration (FDA) [2]. The FDA's Center for Veterinary Medicine is responsible for regulating animal drugs, and any use of human drugs in animals should be under the guidance of a veterinarian [3].

While there are studies on the effects of statins (the class of drug to which Lipitor belongs) in animals, these studies primarily focus on laboratory animals such as rats and mice, not bovines [4]. Furthermore, the studies mainly investigate the short-term effects of these drugs [5].

In summary, while there is no concrete evidence suggesting long-term risks of Lipitor for bovines, it is not approved for use in animals. The potential risks and benefits of using human drugs in animals should be determined by a veterinarian.

Sources:
[1] Mayo Clinic. (2021). Atorvastatin (Oral Route). Retrieved from <https://www.mayoclinic.org/drugs-supplements/atorvastatin-oral-route/description/drg-20063095>
[2] U.S. Food and Drug Administration. (2021). Animal Drugs @ FDA. Retrieved from <https://www.fda.gov/animal-veterinary/animal-drugs-fda>
[3] U.S. Food and Drug Administration. (2021). How to Report Animal Drug Side Effects and Product Problems. Retrieved from <https://www.fda.gov/animal-veterinary/animal-health-literacy/how-report-animal-drug-side-effects-and-product-problems>
[4] National Library of Medicine. (2021). Statins. Retrieved from <https://medlineplus.gov/statins.html>
[5] National Center for Biotechnology Information. (2021). PubMed. Retrieved from <https://pubmed.ncbi.nlm.nih.gov/>